Search | IOVS | ARVO Journals

Showing 1 – 20 of 45

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Research Opportunities October 2024

Data Harmonization, Standardization, and Collaboration for Diabetic Retinal Disease (DRD) Research: Report From the 2024 Mary Tyler Moore Vision Initiative Workshop on Data

PDF

Amitha Domalpally; Ward Fickweiler; S. Robert Levine; Kerry E. Goetz; Brian L. VanderBeek; Aaron Lee; Jeffrey M. Sundstrom; Dorene Markel; Jennifer K. Sun
TAGS: diabetes mellitus, medication therapy management, myopic foveoschisis, retinal diseases, vision, study report
Trans. Vis. Sci. Tech.. 2024; 13(10):4. https://doi.org/10.1167/tvst.13.10.4

ARVO Annual Meeting Abstract June 2024

Disparities in glaucoma and macular degeneration healthcare utilization among persons living with dementia

Angela Chang; Ali G Hamedani; Yineng Chen; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2810.

ARVO Annual Meeting Abstract June 2024

Visual deficits due to diabetic retinal disease

Brian L VanderBeek; Yinxi Yu

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1803.

ARVO Annual Meeting Abstract June 2024

Are Treatment Patterns for Endophthalmitis After Cataract Surgery Following the EVS Trial Recommendations?: An IRIS ® Registry (Intelligent Research in Sight) Analysis

Maurizio Tomaiuolo; Jordan Deaner; Brian L VanderBeek; Zeba A Syed; Binod Acharya; Qiang Zhang; Joel S Schuman; Leslie Hyman

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2424.

ARVO Annual Meeting Abstract June 2023

Practice pattern trends among young retinal specialists: a five-year follow-up

Jonathan C Tsui; Vincent Huang; Sidney A Schechet; Hemang Pandya; Mitul C Mehta; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5254.

ARVO Annual Meeting Abstract June 2023

The Association of Herpes Zoster Ophthalmicus with Stroke: Findings from a Matched Case-Control and Self-Controlled Study of a Large U.S. National Database

Tejus Pradeep; Angela Satya Gupta; Yinxi Yu; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2481.

ARVO Annual Meeting Abstract June 2022

Visit Adherence and Visual Acuity in SCORE2

Brian L VanderBeek; Yinxi Yu; Neal Oden; Paul C Van Veldhuisen; Barbara A Blodi; Michael S Ip; Ingrid U Scott

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2672.

ARVO Annual Meeting Abstract June 2022

Evaluation of Long-Term Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Injections on Renal Function

Daniel Choi; Brendan McGeehan; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1332 – F0166.

ARVO Annual Meeting Abstract June 2022

SGLT2 inhibitors and diabetic retinopathy progression

Jennifer Beth Nadelmann; Charles G Miller; Brendan McGeehan; Yinxi Yu; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2169 – F0232.

ARVO Annual Meeting Abstract June 2022

Association of PPI/H2 Blocker Use and Ocular Toxoplasmosis: Findings from a Large U.S. National Database

Tejus Pradeep; Christopher Conrady; Yinxi Yu; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2543 – A0112.

ARVO Annual Meeting Abstract June 2022

Adherence to dual-energy x-ray absorptiometry scan recommendations and fracture risk in non-infectious uveitis patients

Devin Cohen; Nicholas J Butler; Yinxi Yu; John H Kempen; Lucia Sobrin; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3932 – A0475.

ARVO Annual Meeting Abstract June 2022

Demographic variables and systemic comorbidities associated with diagnosis of chalazion and chalazion incision/excision from a US claims database

Diana Kim; Brendan McGeehan; Cesar A Briceno; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3841.

ARVO Annual Meeting Abstract June 2022

Symptom Based Triage Tool in Ophthalmology

Elana Meer; Meera Suja Ramakrishnan; Gideon Whitehead; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2796 – A0126.

ARVO Annual Meeting Abstract June 2021

Systemic Disease Associations with Angioid Streaks using a U.S. National Healthcare Database

Yafeng Li; Jennifer Beth Nadelmann; Brendan McGeehan; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):172.

ARVO Annual Meeting Abstract June 2021

Associations Between Patient and Eye Care Provider-Related Factors and Endophthalmitis Following Intravitreal Injections

Diana Kim; Geoffrey Emerson; Moshiur Rahman; Joshua D Stein; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1368.

ARVO Annual Meeting Abstract June 2021

Glucagon-like peptide-1 receptor agonists are associated with decreased risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy

Zujaja Tauqeer; Peter Bracha; Peiying Hua; Qi N Cui; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1122.

ARVO Annual Meeting Abstract June 2021

Exposure to glucagon-like peptide 1 receptor (GLP1R) agonists is associated with reduced risk for glaucoma

Qi N Cui; Jacob Sterling; Peiying Hua; Joshua L Dunaief; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1013.

ARVO Annual Meeting Abstract June 2020

Utility of hypercoagulable testing in young CRVO patients

Zujaja Tauqeer; Peter Bracha; Brendan McGeehan; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1303.

ARVO Annual Meeting Abstract June 2020

Female hormonal therapy (FHT) is not associated with retinal vascular occlusions

Jennifer Nadelmann; Delu Song; Yinxi Yu; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1342.

ARVO Annual Meeting Abstract June 2020

Recent practice patterns in acute retinal artery occlusions in the United States

Drew Scoles; Peiying Hua; Brendan McGeehan; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1929.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Data Harmonization, Standardization, and Collaboration for Diabetic Retinal Disease (DRD) Research: Report From the 2024 Mary Tyler Moore Vision Initiative Workshop on Data

Disparities in glaucoma and macular degeneration healthcare utilization among persons living with dementia

Visual deficits due to diabetic retinal disease

Are Treatment Patterns for Endophthalmitis After Cataract Surgery Following the EVS Trial Recommendations?: An IRIS ® Registry (Intelligent Research in Sight) Analysis

Practice pattern trends among young retinal specialists: a five-year follow-up

The Association of Herpes Zoster Ophthalmicus with Stroke: Findings from a Matched Case-Control and Self-Controlled Study of a Large U.S. National Database

Visit Adherence and Visual Acuity in SCORE2

Evaluation of Long-Term Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Injections on Renal Function

SGLT2 inhibitors and diabetic retinopathy progression

Association of PPI/H2 Blocker Use and Ocular Toxoplasmosis: Findings from a Large U.S. National Database

Adherence to dual-energy x-ray absorptiometry scan recommendations and fracture risk in non-infectious uveitis patients

Demographic variables and systemic comorbidities associated with diagnosis of chalazion and chalazion incision/excision from a US claims database

Symptom Based Triage Tool in Ophthalmology

Systemic Disease Associations with Angioid Streaks using a U.S. National Healthcare Database

Associations Between Patient and Eye Care Provider-Related Factors and Endophthalmitis Following Intravitreal Injections

Glucagon-like peptide-1 receptor agonists are associated with decreased risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy

Exposure to glucagon-like peptide 1 receptor (GLP1R) agonists is associated with reduced risk for glaucoma

Utility of hypercoagulable testing in young CRVO patients

Female hormonal therapy (FHT) is not associated with retinal vascular occlusions

Recent practice patterns in acute retinal artery occlusions in the United States

To View More...

You must be signed into an individual account to use this feature.